Skip to content
Disclosery

EXANE DERIVATIVES: LOW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LOW, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 12 LOW shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 12 shares
    Change vs previous 13F -1,796 shares

    <0.01% of the 13F portfolio, value $2,096.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,808 shares
    Change vs previous 13F +1,808 shares

    0.1% of the 13F portfolio, value $365,557.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 0 shares
    Change vs previous 13F -488 shares

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2021-06-30
    13F 488 shares
    Change vs previous 13F +19 shares

    0.02% of the 13F portfolio, value $94,810.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 469 shares
    Change vs previous 13F +462 shares

    0.03% of the 13F portfolio, value $89,196.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-12-31
    13F 7 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,124.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-09-30
    13F/A 7 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,161.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).